These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21488172)
1. Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions. Lonardi S; Manera C; Marucci R; Santoro A; Lorenzi L; Facchetti F Diagn Cytopathol; 2011 May; 39(5):313-7. PubMed ID: 21488172 [TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338 [TBL] [Abstract][Full Text] [Related]
3. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Facchetti F; Lonardi S; Gentili F; Bercich L; Falchetti M; Tardanico R; Baronchelli C; Lucini L; Santin A; Murer B Virchows Arch; 2007 Sep; 451(3):669-80. PubMed ID: 17609977 [TBL] [Abstract][Full Text] [Related]
4. The diagnostic role of claudins in serous effusions. Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990 [TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [TBL] [Abstract][Full Text] [Related]
6. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
7. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Su XY; Li GD; Liu WP; Xie B; Jiang YH Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004 [TBL] [Abstract][Full Text] [Related]
8. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Bassarova AV; Nesland JM; Davidson B Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization. Afify AM; Stern R; Michael CW Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268 [TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395 [TBL] [Abstract][Full Text] [Related]
12. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863 [TBL] [Abstract][Full Text] [Related]
13. Serous effusions in malignant lymphomas: a review. Das DK Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559 [TBL] [Abstract][Full Text] [Related]
14. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A; Lynne LC; Howell L Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576 [TBL] [Abstract][Full Text] [Related]
15. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions. Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433 [TBL] [Abstract][Full Text] [Related]
16. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Shield PW; Koivurinne K Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095 [TBL] [Abstract][Full Text] [Related]
17. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY; Li GD; Liu HB; Jiang LL Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions. Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847 [TBL] [Abstract][Full Text] [Related]
19. The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology. Nagel H; Hemmerlein B; Ruschenburg I; Hüppe K; Droese M Pathol Res Pract; 1998; 194(11):759-64. PubMed ID: 9842634 [TBL] [Abstract][Full Text] [Related]
20. Cytological study of serous effusions with the aid of tumour markers. Ray K; Mittal S; Gupta H; Jain M J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]